Close Menu

tuberculosis

NEW YORK (GenomeWeb News) — Roche Molecular Systems has sued Cepheid for allegedly infringing a US patent assigned to Roche and covering PCR-based methods for detecting Mycobacterium tuberculosis and drug resistance, according to court documents filed this week.

NEW YORK (GenomeWeb News) – Somalogic said this week that it has received additional funding from the Bill & Melinda Gates Foundation for the development and validation of tuberculosis biomarker assays based on its Somamer technology.

NEW YORK (GenomeWeb) – An international team has uncovered a gene expression signature in host blood that appears to have potential for more accurately detecting and diagnosing tuberculosis infections in children.

NEW YORK (GenomeWeb) — Cepheid's high-burden developing country (HBDC) program — the initiative through which it sells its GeneXpert system and related tuberculosis/drug-resistance test to resource-poor territories at a subsidized, discounted price — continues to serve as an important revenue dri

The laboratory of David Alland at Rutgers Biomedical and Health Sciences' New Jersey Medical School has been awarded a five-year grant from the National Institutes of Health to further develop a highly multiplexed assay to detect multiple drug-resistant strains of tuberculosis us

Scientists from a number of Chinese research institutions and government agencies have published the first peer-reviewed paper describing the clinical validation of a tuberculosis drug-resistance assay developed by Xiamen-based molecular diagnostics firm Zeesan Biotech.

Harvard University and Akonni Biosystems have teamed up to develop and test an amplification array-based diagnostic for multi-drug-resistant and extreme-drug-resistant tuberculosis.

NEW YORK (GenomeWeb News) – Enigma Diagnostics today announced a second grant from the UK's Technology Strategy Board to further develop the company's multidrug-resistant tuberculosis (MDR-TB) test on its Enigma Mini Laboratory system.

NEW YORK (GenomeWeb News) – Researchers from Baylor College of Medicine have received a $3 million grant from the National Institutes of Health to collaborate with partners in Africa to study genetic factors involved in tuberculosis and HIV.

NEW YORK (GenomeWeb News) – For the past eight years Menon Biosensors has operated in near secrecy developing a technology with US government backing to detect some of the world's deadliest biothreat pathogens.

Pages

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.